Recruiting A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B NCT07200193 Conditions Blood-Borne Infections, Chronic Disease, Chronic Hepaititis B, +15 more Locations Hospices Civils De Leon — Lyon, France Queen Mary Hospital, The University of Hong Kong — Hong Kong New Zealand Clinical Research — Auckland, New Zealand King's College Hospital — London, United Kingdom View Trial Details
Recruiting Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B NCT07328711 Conditions Chronic Hepaititis B Locations Peking University People's Hospital — Beijing, Beijing Municipality, China View Trial Details
Completed An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue Therapy NCT02068365 Conditions Chronic Hepaititis B Locations Prince of Wales Hospital — Shatin, Hong Kong View Trial Details
